Article Correctness Is Author's Responsibility: NFCR-funded translational cancer research project receives Virginia Catalyst grant

(National Foundation for Cancer Research) A translational research project supported by the National Foundation for Cancer Research (NFCR) has been awarded $700,000 from Virginia Catalyst to advance its lead cancer drug candidate. NFCR's $400,000 translational research support for the project in 2017 and 2018 is in addition to over $850,000 in basic cancer research funding which the organization has provided to Dr. Fisher and his lab since 2008.